Clinical Trial Update: Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine [Phase 4]

View source ↗

Summary

Phase 4 open-label multicenter trial assessing safety of redosing with the ADACEL vaccine. Results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Tetanus, Diphtheria | Phase 4 | Status: COMPLETED | Results posted: 2010-07-22